We call our vision Pi-squared:
We are passionately dedicated to developing effective and novel treatments for debilitating neurodegenerative disorders.
We are applying innovation to drug development in neurosciences by capitalizing on scientific and clinical insights, so that we can move towards new therapeutic solutions rapidly and efficiently with substantially lower development risk.
We are committed to improving the lives of patients, their families and caregivers.
We aim to develop breakthrough therapies that can change the lives of patients with neurodegenerative disorders.